217 related articles for article (PubMed ID: 26163155)
1. Ventilatory gas exchange and early response to cardiac resynchronization therapy.
Kim CH; Olson LJ; Shen WK; Cha YM; Johnson BD
J Heart Lung Transplant; 2015 Nov; 34(11):1430-5. PubMed ID: 26163155
[TBL] [Abstract][Full Text] [Related]
2. Interplay between right ventricular function and cardiac resynchronization therapy: an analysis of the CARE-HF trial (Cardiac Resynchronization-Heart Failure).
Damy T; Ghio S; Rigby AS; Hittinger L; Jacobs S; Leyva F; Delgado JF; Daubert JC; Gras D; Tavazzi L; Cleland JG
J Am Coll Cardiol; 2013 May; 61(21):2153-60. PubMed ID: 23541971
[TBL] [Abstract][Full Text] [Related]
3. Hospital-based and telemonitoring guided home-based training programs: effects on exercise tolerance and quality of life in patients with heart failure (NYHA class III) and cardiac resynchronization therapy. A randomized, prospective observation.
Smolis-Bąk E; Dąbrowski R; Piotrowicz E; Chwyczko T; Dobraszkiewicz-Wasilewska B; Kowalik I; Kazimierska B; Jędrzejczyk B; Smolis R; Gepner K; Maciąg A; Sterliński M; Szwed H
Int J Cardiol; 2015 Nov; 199():442-7. PubMed ID: 26276068
[TBL] [Abstract][Full Text] [Related]
4. Effect of Cardiac Resynchronization Therapy on Exercise-Induced Pulmonary Hypertension and Right Ventricular-Arterial Coupling.
Martens P; Verbrugge FH; Bertrand PB; Verhaert D; Vandervoort P; Dupont M; Tang WHW; Janssens S; Mullens W
Circ Cardiovasc Imaging; 2018 Sep; 11(9):e007813. PubMed ID: 30354673
[TBL] [Abstract][Full Text] [Related]
5. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
[TBL] [Abstract][Full Text] [Related]
6. Comparison of low versus high (>40 mm Hg) pulse pressure to predict the benefit of cardiac resynchronization therapy for heart failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial).
Sherazi S; Goldenberg I; Moss AJ; Solomon S; Kutyifa V; McNitt S; Shah AH; Huang DT; Aktas MK; Zareba W; Barsheshet A
Am J Cardiol; 2014 Oct; 114(7):1053-8. PubMed ID: 25118116
[TBL] [Abstract][Full Text] [Related]
7. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.
Young JB; Abraham WT; Smith AL; Leon AR; Lieberman R; Wilkoff B; Canby RC; Schroeder JS; Liem LB; Hall S; Wheelan K;
JAMA; 2003 May; 289(20):2685-94. PubMed ID: 12771115
[TBL] [Abstract][Full Text] [Related]
8. Relationship Between Reverse Remodeling and Cardiopulmonary Exercise Capacity in Heart Failure Patients Undergoing Cardiac Resynchronization Therapy.
Mastenbroek MH; Van't Sant J; Versteeg H; Cramer MJ; Doevendans PA; Pedersen SS; Meine M
J Card Fail; 2016 May; 22(5):385-94. PubMed ID: 26363091
[TBL] [Abstract][Full Text] [Related]
9. Echocardiographic changes after cardiac resynchronisation therapy.
Praus R; Haman L; Tauchman M; Pudil R; Blaha V; Parizek P
Kardiol Pol; 2012; 70(12):1250-7. PubMed ID: 23264243
[TBL] [Abstract][Full Text] [Related]
10. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
[TBL] [Abstract][Full Text] [Related]
11. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
[TBL] [Abstract][Full Text] [Related]
12. A metric for evaluating the cardiac response to resynchronization therapy.
Ge Y; Ruwald AC; Kutyifa V; McNitt S; Polonsky S; Klein H; Goldenberg I; Solomon SD; Foster E; Zareba W; Moss AJ
Am J Cardiol; 2014 Apr; 113(8):1371-7. PubMed ID: 24607029
[TBL] [Abstract][Full Text] [Related]
13. Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Follow-Up Substudy.
Biton Y; Moss AJ; Kutyifa V; Mathias A; Sherazi S; Zareba W; McNitt S; Polonsky B; Barsheshet A; Brown MW; Goldenberg I
Circ Heart Fail; 2015 Sep; 8(5):921-6. PubMed ID: 26179186
[TBL] [Abstract][Full Text] [Related]
14. Right ventricular septal pacing as alternative for failed left ventricular lead implantation in cardiac resynchronization therapy candidates.
Alhous MH; Small GR; Hannah A; Hillis GS; Frenneaux M; Broadhurst PA
Europace; 2015 Jan; 17(1):94-100. PubMed ID: 25359384
[TBL] [Abstract][Full Text] [Related]
15. Right ventricular function, pulmonary pressure estimation, and clinical outcomes in cardiac resynchronization therapy.
Campbell P; Takeuchi M; Bourgoun M; Shah A; Foster E; Brown MW; Goldenberg I; Huang DT; McNitt S; Hall WJ; Moss A; Pfeffer MA; Solomon SD;
Circ Heart Fail; 2013 May; 6(3):435-42. PubMed ID: 23524528
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of preimplantation B-type natriuretic peptide level for predicting response to cardiac resynchronization therapy.
Lellouche N; De Diego C; Cesario DA; Vaseghi M; Horowitz BN; Mahajan A; Wiener I; Boyle NG; Fonarow GC; Shivkumar K
Am J Cardiol; 2007 Jan; 99(2):242-6. PubMed ID: 17223426
[TBL] [Abstract][Full Text] [Related]
17. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial.
Khan FZ; Virdee MS; Palmer CR; Pugh PJ; O'Halloran D; Elsik M; Read PA; Begley D; Fynn SP; Dutka DP
J Am Coll Cardiol; 2012 Apr; 59(17):1509-18. PubMed ID: 22405632
[TBL] [Abstract][Full Text] [Related]
18. Acute effects of withdrawal of cardiac resynchronization therapy on left and right ventricular function, dyssynchrony, and contractile function in patients with New York Heart Association functional class I/II heart failure: MADIT-CRT.
Knappe D; Pouleur AC; Shah AM; Bourgoun M; Brown MW; Foster E; Pfeffer MA; Moss AJ; Solomon SD;
J Card Fail; 2013 Mar; 19(3):149-55. PubMed ID: 23482074
[TBL] [Abstract][Full Text] [Related]
19. Effect of cardiac resynchronization therapy in patients with New York Heart Association functional class IV heart failure.
van Bommel RJ; van Rijnsoever E; Borleffs CJ; Delgado V; Marsan NA; Bertini M; Schalij MJ; Bax JJ
Am J Cardiol; 2010 Oct; 106(8):1146-51. PubMed ID: 20920655
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Extrapolation of Clinical Benefits Among Patients With Mild Heart Failure Receiving Cardiac Resynchronization Therapy: Analysis of the 5-Year Follow-Up From the REVERSE Study.
Gold MR; Padhiar A; Mealing S; Sidhu MK; Tsintzos SI; Abraham WT
JACC Heart Fail; 2015 Sep; 3(9):691-700. PubMed ID: 26277764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
